Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War
Emergent BioSolutions received a $22.3 million order modification to supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War. The order is part of an existing contract to provide the vaccine for military use. According to the company, this supports preparedness against biological threats like anthrax.
How this was made
The 30-second read
Why it matters
The contract modification confirms ongoing demand for anthrax vaccine and may bolster the company's revenue outlook, though the amount is modest relative to its total earnings.
Market read
A new government contract adds incremental revenue and reinforces the company's defense‑biotech positioning, offering a modest bullish catalyst.
What to watch
Potential future extensions or volume increases beyond the $22.3 M could amplify revenue impact if not disclosed.
Background
Emergent BioSolutions is a leading supplier of medical countermeasures for biological threats, with a history of government contracts for vaccines such as BioThrax.
Ticker impact
Emergent BioSolutions announced a $22.3 million modification to its IDIQ contract to supply BioThrax anthrax vaccine to the U.S. Department of War.
likely modest upside as investors price in the new contract revenue
A $22 M government contract is material for a mid‑cap biotech but not large enough to drive a sharp move; the news is new and confirms ongoing demand.
Market effects
Supports the broader defense‑biotech sector by confirming continued government spend on counter‑bioterror products.
U.S. defense contractors may see slight positive sentiment.
Limited to investors tracking U.S. government contract pipelines.
Counterpoint
The contract size is too small to offset broader market risks for biotech stocks, so the news may be already priced in.
Key entities
- companyEmergent BioSolutions Inc.
U.S. biotech firm supplying BioThrax vaccine to the Department of War.
- governmentU.S. Department of War
The contracting agency for the anthrax vaccine supply.



